Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)

From 1365 to 1382, 205 cases of Acute lymphoblastic leukemia (ALL) were refered to our Center. 160 cases achived complete remission and entered our clinical trial of CNS relapse which were under consideration. The patients included 98 men and 62 women with an average age of 32 years (range 4-61 year...

Full description

Bibliographic Details
Main Authors: Azarm T, Jahani M, Amini A.Gh, Saghfi M.R
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-07-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4533.pdf&manuscript_id=4533
_version_ 1797759908672700416
author Azarm T
Jahani M
Amini A.Gh
Saghfi M.R
author_facet Azarm T
Jahani M
Amini A.Gh
Saghfi M.R
author_sort Azarm T
collection DOAJ
description From 1365 to 1382, 205 cases of Acute lymphoblastic leukemia (ALL) were refered to our Center. 160 cases achived complete remission and entered our clinical trial of CNS relapse which were under consideration. The patients included 98 men and 62 women with an average age of 32 years (range 4-61 years). 160 of 205 cases had complete remission with a rate about 78%.The latter group was entered into our clinical trial. The patients were followed for 30 months after starting maintenance therapy. All patients underwent CNS prophelaxy by CNS Irradiation with 14 GY and Intratechal Methotrexate in¬jection for 6 weeks. 24 cases had relapsed. The age of CNS relapsed patients were between 9 to 58 years (Mean 31y). Patient Sex: 11 male of 91, 13 female of 69."nResults: 1 case showed CNS relapse after 4 months of starting maitenance therapy. 19 cases relapsed in the duration of 6-18 months after starting maintenance therapy. 2 cases relapsed within 24 & 28 months after starting maintenance therapy. The Statistic analysis are summarized as follows: 1-CNS relapse of ALLin the Females are more than Males (p=0.001). 2-CNS relapse of ALL in the age groupe older than 12 years were higher."n3-CNS relapse of ALL in those patients with bone marrow failure in responding to first period of treatment were higher (p=0.002)."n4-CNS relapse of ALL in those patients with Leukocytosis more than 40.000/ul were higher (p=0.003). 5-The first Symptom of CNS relapse was severe headache (100%). 6-CNS relapse of ALL were in 18 months period of strating maintenance therapy. 7-CNS relapse of ALL in those patients with Type II ALL were more than Type I, with a rate of 18.7 % and 4.7% respectively.
first_indexed 2024-03-12T18:52:13Z
format Article
id doaj.art-0fdf6a5c8c46400eb110ed520c7b6a24
institution Directory Open Access Journal
issn 2008-3009
2008-2207
language English
last_indexed 2024-03-12T18:52:13Z
publishDate 2005-07-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-0fdf6a5c8c46400eb110ed520c7b6a242023-08-02T07:11:47ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072005-07-01221620Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)Azarm TJahani MAmini A.GhSaghfi M.RFrom 1365 to 1382, 205 cases of Acute lymphoblastic leukemia (ALL) were refered to our Center. 160 cases achived complete remission and entered our clinical trial of CNS relapse which were under consideration. The patients included 98 men and 62 women with an average age of 32 years (range 4-61 years). 160 of 205 cases had complete remission with a rate about 78%.The latter group was entered into our clinical trial. The patients were followed for 30 months after starting maintenance therapy. All patients underwent CNS prophelaxy by CNS Irradiation with 14 GY and Intratechal Methotrexate in¬jection for 6 weeks. 24 cases had relapsed. The age of CNS relapsed patients were between 9 to 58 years (Mean 31y). Patient Sex: 11 male of 91, 13 female of 69."nResults: 1 case showed CNS relapse after 4 months of starting maitenance therapy. 19 cases relapsed in the duration of 6-18 months after starting maintenance therapy. 2 cases relapsed within 24 & 28 months after starting maintenance therapy. The Statistic analysis are summarized as follows: 1-CNS relapse of ALLin the Females are more than Males (p=0.001). 2-CNS relapse of ALL in the age groupe older than 12 years were higher."n3-CNS relapse of ALL in those patients with bone marrow failure in responding to first period of treatment were higher (p=0.002)."n4-CNS relapse of ALL in those patients with Leukocytosis more than 40.000/ul were higher (p=0.003). 5-The first Symptom of CNS relapse was severe headache (100%). 6-CNS relapse of ALL were in 18 months period of strating maintenance therapy. 7-CNS relapse of ALL in those patients with Type II ALL were more than Type I, with a rate of 18.7 % and 4.7% respectively.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4533.pdf&manuscript_id=4533 CNS– relapse
spellingShingle Azarm T
Jahani M
Amini A.Gh
Saghfi M.R
Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
International Journal of Hematology-Oncology and Stem Cell Research
CNS– relapse
title Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
title_full Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
title_fullStr Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
title_full_unstemmed Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
title_short Central Nervous System Relapse in Acute Lymphoblastic Leukemia (Study on 160 cases)
title_sort central nervous system relapse in acute lymphoblastic leukemia study on 160 cases
topic CNS– relapse
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4533.pdf&manuscript_id=4533
work_keys_str_mv AT azarmt centralnervoussystemrelapseinacutelymphoblasticleukemiastudyon160cases
AT jahanim centralnervoussystemrelapseinacutelymphoblasticleukemiastudyon160cases
AT aminiagh centralnervoussystemrelapseinacutelymphoblasticleukemiastudyon160cases
AT saghfimr centralnervoussystemrelapseinacutelymphoblasticleukemiastudyon160cases